This week in Clipboard Health’s Nursing News round-up …
Laboratory Studies Show Honeybee Venom Could Potentially Fight Cancer
In laboratory studies, researchers found that melittin, the active component found in honeybee venom can kill and disrupt the reproduction of cancer cells. Melittin combined with chemotherapy drugs seemed to be even more effective when used together as opposed to using them separately to shrink breast cancer tumors.
Tylenol Changes Our Perception of Risk
A recent series of small-scale studies indicated that acetaminophen, known by most people under the brand name Tylenol, seems to change the way that we perceive risk and the way we act during risky activities. The studies showed that people who took acetaminophen were more likely to view risks less negatively and were more willing to take risks.
Young Children Use Both Brain Hemispheres to Process Language
In adults, the left hemisphere of the brain is used to process language. If that hemisphere in an adult is damaged, such as from a stroke or head injury, they could lose the ability to use and process language. A new study found that young children don’t have the same problem. Children use both hemispheres to process language, meaning if they suffer a head injury, their ability to recover and continue learning and using language is not as severely affected.
Keto Diet Alters Gut Fungi, May Lower Alzheimer’s Risk
A recent study found that people who ate a modified Mediterranean-style ketogenic diet (MMKD) saw altered fungi in their gut that reduced Alzheimer’s disease biomarkers. The study specifically looked at people with mild cognitive impairment (MCI), a risk factor for Alzheimer’s disease, as scientists had identified a distinctive combination of gut bacteria in people with MCI.
Vitamin D Deficiency May Increase Risk of Getting COVID-19
A new study indicates that people with a vitamin D deficiency, absorbed into the human body from sunlight, could be twice as likely to become infected with COVID-19.
Children Could Have COVID-19 and Antibodies at the Same Time
A new study that included approximately 6,300 children found that some kids can have both the COVID-19 virus and its antibodies at the same time. Normally during a viral infection, once antibodies are detected, the virus will already be gone from the system and undetectable. Further research will focus on whether or not someone with both the virus and antibodies can infect other people and how COVID-19 antibodies affect a person’s immunity.
Race for the Vaccine: Coronavirus Vaccine Updates
Trials continue and vaccine developers make a pledge to stick to their testing standards.
The following nine vaccine developers currently leading the COVID-19 vaccine race made a pledge to uphold their testing standards and not let outside pressures affect the process: Pfizer, GlaxoSmithKline, AstraZeneca, Johnson & Johnson, Merck & Co, Moderna, Novavax, Sanofi, and BioNTech. No Chinese-based companies or institutions participated in the statement.
BioNTech and its partner Pfizer gained approval in Germany for Phase II and Phase III trial testing for its vaccine within its home country. The company is on track to request approval for the vaccine by October.
Russia finished Phase II trials of its second COVID-19 vaccine.